Search
Now showing items 1-4 of 4
Leishmaniasis in northern and western Africa: a review
(2009)
Leishmaniasis, one of the highly neglected diseases is currently a significant health problem in northern Africa with a rising concern in western Africa because of co-infection with the Human Immunodeficiency Virus (HIV). ...
Development of Leishmania vaccines: predicting the future from past and present experience
(Journal of Biomedical Research, 2013-03)
Leishmaniasis is a disease that ranges in severity from skin lesions to serious disfigurement and fatal systemic infection. Resistance to infection is associated with a T-helper-1 immune response that activates macrophages ...
A Review of Adjuvants for Leishmania Vaccine Candidates.
(PubMed, 2010)
Over the last decade, there has been a flurry of research on adjuvants for vaccines, and several novel adjuvants are now licensed products or in late stage clinical development. The success of adjuvants in enhancing the ...
Immunology of leishmaniasis
(2013-06)
Resolution of leishmanial infection is dependent on the coordinated interactions between components of cell mediated immune response, central to which is the activation of targeted T-cell populations for appropriate cytokine ...